Strong team known for regularly representing global investment banks and issuers in the biotechnology and pharmaceutical spheres. Experienced in dealing with IPOs and follow-on offerings.
"They're absolutely great," reports an interviewee, adding: "My experience has been exceptional - I value their opinions and the fact that they will rise to any occasion."
"The team is highly sophisticated and client-oriented," comments a source, who adds: "Latham is exceptionally good at making cross-geographic teams work for the client's benefit."
Acted for J.P. Morgan as the underwriters in a $151.8 million common stock offering of shares by Akebia Therapeutics.
Associate Jennifer Yoon focuses her practice on capital markets transactions and securities matters, including share offerings, IPOs and follow-on offerings. She often works with clients in the life sciences sector.
"She is always accessible and knowledgeable." "She is one of my favorite attorneys; she is very practical and super efficient." "She is exceptionally talented on the law and a high-quality client service provider. She is extremely professional and unflappable."
John Chory focuses his practice on both corporate transactions and securities offerings. He has significant experience advising on IPOs.
Peter Handrinos draws widespread praise for his extensive experience advising on IPOs and other high-value capital markets transactions. He counts global financial institutions and pharmaceutical companies among his clients.
"He is very practical, diplomatic, very knowledgeable, he considers a lot of factors and very quickly boils it down - he great to have on your team." "He is a great biotech lawyer who takes a practical approach for his clients."